Newsletter
Expert analysis on longevity, GLP-1 therapies, synbiotics, digital health, and wellness innovation.
Latest issue 2026-10-17 · 7 pieces
Equity
Equitable distribution of diagnostics and medicines requires deliberate redesign of supply chains so that every clinic can obtain reliable tools and treatments regardless of location or patient income.
2026-10-17 · Read the essay
Population health
Population health approaches across India are moving from hospital-centric treatment toward community-level prevention and coordination that spans urban and rural settings.
Homecare
Hospital-at-home programs now let nurses direct continuous monitoring and care decisions for patients who would otherwise occupy inpatient beds.
Health economics
Prevention programs shift financial burdens across payers, providers, and patients, yet realized savings frequently land outside the original investor.
Synbiotics
Synbiotics are shifting from consumer supplements into defined clinical pathways that link gut modulation directly to diagnosis, monitoring, and follow-up.
Longevity
Operators evaluating longevity clinics need clear methods to assess biological age claims against measurable clinical outputs.
Equity
Equitable distribution of diagnostics and medicines requires deliberate redesign of supply chains, financing, and clinical workflows to reach every patient population without bias.
GLP-1
GLP-1 therapies now require attention to access barriers, patient follow-through, and gastrointestinal effects that shape daily practice beyond initial weight reduction.